Tandem Diabetes Care, Inc. (NASDAQ:TNDM) reached 17.21% versus a 1-year low price of $2.15. The stock was last seen 8.62% higher, reaching at $2.52 on 11/08/2017. At recent session, the prices were hovering between $2.34 and $2.72. This company shares are 223.02% off its target price of $8.14 and the current market capitalization stands at $26.79M. The recent change has given its price a -50.88% deficit over SMA 50 and -92.25% deficit over its 52-week high. The stock witnessed -52.5% declines, -44% declines and -71.65% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found TNDM’s volatility during a week at 10.45% and during a month it has been found around 12.95%.

Tandem Diabetes Care, Inc. (TNDM) Top Holders

Institutional investors currently hold around $14 million or 26.7% in TNDM stock. Look at its top three institutional owners. Frontier Capital Management Co Llc owns $11.23 million in Tandem Diabetes Care, Inc., which represents roughly 41.92% of the company’s market cap and approximately 80.21% of the institutional ownership. Similar statistics are true for the second largest owner, Wasatch Advisors Inc, which owns 317,264 shares of the stock are valued at $736 thousand. The third largest holder is Tpg Group Holdings (Sbs) Advisors, Inc., which currently holds $579 thousand worth of this stock and that ownership represents nearly 2.16% of its market capitalization.

Tandem Diabetes Care, Inc. 13F Filings

At the end of 09/30/2017 reporting period, 28 institutional holders increased their position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) by some 4,477,963 shares, 43 decreased positions by 609,698 and 13 held positions by 1,083,828. That puts total institutional holdings at 6,171,489 shares, according to SEC filings. The stock grabbed 13 new institutional investments totaling 80,465 shares while 23 institutional investors sold out their entire positions totaling 338,170 shares.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Insider Trades

Multiple company employees have indulged in significant insider trading. Tandem Diabetes Care, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that PRESIDENT & CEO Blickenstaff Kim D has acquired 285,700 shares of Tandem Diabetes Care, Inc. (TNDM) in trading session dated Oct. 13, 2017. These shares are worth $999,950 and were traded at $3.5 each. The SEC filing shows that Blickenstaff Kim D performed a purchase of 1,600,000 shares. The PRESIDENT & CEO added these shares by way of transaction on Mar. 23, 2017. The company’s shares were assimilated at $1.25 per share worth to an investment of some $2,000,000 on account of Blickenstaff Kim D.

PRESIDENT & CEO, Blickenstaff Kim D, purchased 1,600,000 common shares of Tandem Diabetes Care, Inc. (TNDM) in the open market. In a transaction dated Mar. 23, 2017, the shares were bought at an average price of $1.25, giving away a sum of $2,000,000. After this purchase, 2,007,939 common shares of TNDM are directly owned by the insider, with total stake valued at $5,060,006.

In the transaction dated Aug. 01, 2016, the great number of shares disposed came courtesy the EVP, CHIEF OPERATING OFFICER; Sheridan John F disposed a total of 15,000 shares at an average price of $6.52, amounting to approximately $97,800. The insider now directly owns 7,763 shares worth $19,563.

Tandem Diabetes Care, Inc. (TNDM) Analyst Guide

Several analysts have released their opinion on Tandem Diabetes Care, Inc. (NASDAQ:TNDM), with 2 analysts believing it is a strong buy. Whereas 5 of them predict the stock is a hold. Also, there are 0 buy, 1 sell and 0 strong sell ratings, collectively assigning a 2.63 average brokerage recommendation.

SHARE
Previous articleNorthern Dynasty Minerals Ltd. (NAK) recently purchased by insider Share Ownership Details
Next article11 hedge funds sold their entire positions in TearLab Corporation (TEAR)